drugset / Trial / NCT05554965
Endoscopic Hemostatic and Sedative Treatment of Esophageal and Gastric Variceal Bleeding
Non-randomizedParallel-groupSingle-blindTreatment
Summary
Remazolam besylate was used for sedation during endoscopic hemostasis in patients with esophageal and gastric varices rupture and bleeding in liver cirrhosis. The onset time, recovery time and incidence of adverse reactions were observed.
Timeline
- Start
- 2022-02-10
- Primary completion
- 2022-10-30
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 1.5 mg/kg | — |
| Subject | Remimazolam | Small molecule | 0.1 mg/kg | — |
| Subject | Remimazolam | Small molecule | 0.3 mg/kg | — |
Indications
No indication recorded.